ZAMAGNI, ELENA
ZAMAGNI, ELENA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
Elena Zamagni; E. Zamagni; ZAMAGNI E
Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma
2024 Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A.
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials
2024 Gentile M.; Vigna E.; Palmieri S.; Galli M.; Derudas D.; Mina R.; Pepa R.D.; Zambello R.; Martino E.A.; Bruzzese A.; Mangiacavalli S.; Zamagni E.; Califano C.; Musso M.; Conticello C.; Cerchione C.; Mele G.; Renzo N.D.; Offidani M.; Tarantini G.; Casaluci G.M.; Rago A.; Ria R.; Uccello G.; Barilà G.; Palumbo G.; Pompa A.; Vincelli D.; Brunori M.; Accardi F.; Amico V.; Amendola A.; Fontana R.; Bongarzoni V.; Rossini B.; Cotzia E.; Gozzetti A.; Rizzi R.; Sgherza N.; Ferretti E.; Bertuglia G.; Nappi D.; Petrucci M.T.; Raimondo F.D.; Neri A.; Morabito F.; Musto P.
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma
2024 Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L
Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features
2024 Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.
Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis
2024 Charliński G.; Steinhardt M.; Rasche L.; Gonzalez-Calle V.; Peña C.; Parmar H.; Wiśniewska-Piąty K.; Dávila Valls J.; Olszewska-Szopa M.; Usnarska-Zubkiewicz L.; Gozzetti A.; Ciofini S.; Gentile M.; Zamagni E.; Kurlapski M.; Legieć W.; Vesole D.H.; Jurczyszyn A.
Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight
2024 Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa
Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients
2024 Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni, Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina
Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?
2024 Autore, Francesco; Bramanti, Stefania; Lessi, Federica; Innocenti, Idanna; Galli, Eugenio; Rocchi, Serena; Ribolla, Rossella; Derudas, Daniele; Oliva, Stefania; Stefanoni, Paola; Marcatti, Magda; Schenone, Angelo; La Nasa, Giorgio; Crippa, Claudia; Zamagni, Elena; Riva, Marcello; Mazza, Rita; Mannina, Daniele; Sica, Simona; Bacigalupo, Andrea; Laurenti, Luca
Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial
2023 Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P.; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F.
Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results
2023 Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broijl, Annemiek
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
2023 Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann, Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta
High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients
2023 Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S.; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C.
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial
2023 Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C.
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
2023 Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tacchetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M.
Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature
2023 Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Alessandro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia
Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining
2023 Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D.
New Developments in Myeloma Treatment and Response Assessment
2023 Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C.
Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells
2023 Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider
Oxytocin Modulates Osteogenic Commitment in Human Adipose-Derived Stem Cells
2023 Petrocelli, Giovannamaria; Abruzzo, Provvidenza Maria; Pampanella, Luca; Tassinari, Riccardo; Marini, Serena; Zamagni, Elena; Ventura, Carlo; Facchin, Federica; Canaider, Silvia
Pomalidomide combinations are a safe and effective option after daratumumab failure
2023 Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma | Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathi...os; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials | Gentile M.; Vigna E.; Palmieri S.; Galli M.; Derudas D.; Mina R.; Pepa R.D.; Zambello R.; Martino... E.A.; Bruzzese A.; Mangiacavalli S.; Zamagni E.; Califano C.; Musso M.; Conticello C.; Cerchione C.; Mele G.; Renzo N.D.; Offidani M.; Tarantini G.; Casaluci G.M.; Rago A.; Ria R.; Uccello G.; Barilà G.; Palumbo G.; Pompa A.; Vincelli D.; Brunori M.; Accardi F.; Amico V.; Amendola A.; Fontana R.; Bongarzoni V.; Rossini B.; Cotzia E.; Gozzetti A.; Rizzi R.; Sgherza N.; Ferretti E.; Bertuglia G.; Nappi D.; Petrucci M.T.; Raimondo F.D.; Neri A.; Morabito F.; Musto P. | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 11157-Article Text-81532-2-10-20231227.pdf |
| International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma | Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pér...ez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L | 2024-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features | Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; M...azzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M. | 2024-01-01 | NATURE COMMUNICATIONS | - | 1.01 Articolo in rivista | 41467_2024_Article_45000.pdf; 41467_2024_45000_MOESM7_ESM.zip |
| Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment—67 Patients Multicenter Analysis | Charliński G.; Steinhardt M.; Rasche L.; Gonzalez-Calle V.; Peña C.; Parmar H.; Wiśniewska-Piąty ...K.; Dávila Valls J.; Olszewska-Szopa M.; Usnarska-Zubkiewicz L.; Gozzetti A.; Ciofini S.; Gentile M.; Zamagni E.; Kurlapski M.; Legieć W.; Vesole D.H.; Jurczyszyn A. | 2024-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-16-01592-v2.pdf |
| Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight | Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena...; Cavo, Michele; Petrucci, Maria Teresa | 2024-01-01 | LEUKEMIA RESEARCH REPORTS | - | 1.01 Articolo in rivista | Severe SARS-CoV-2.pdf |
| Single-Cell DNA Sequencing Reveals an Evolutionary Pattern of CHIP in Transplant Eligible Multiple Myeloma Patients | Borsi, Enrica; Vigliotta, Ilaria; Poletti, Andrea; Mazzocchetti, Gaia; Solli, Vincenza; Zazzeroni..., Luca; Martello, Marina; Armuzzi, Silvia; Taurisano, Barbara; Kanapari, Ajsi; Pistis, Ignazia; Zamagni, Elena; Pantani, Lucia; Rocchi, Serena; Mancuso, Katia; Tacchetti, Paola; Rizzello, Ilaria; Rizzi, Simonetta; Dan, Elisa; Sinigaglia, Barbara; Cavo, Michele; Terragna, Carolina | 2024-01-01 | CELLS | - | 1.01 Articolo in rivista | - |
| Which is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome? | Autore, Francesco; Bramanti, Stefania; Lessi, Federica; Innocenti, Idanna; Galli, Eugenio; Rocchi..., Serena; Ribolla, Rossella; Derudas, Daniele; Oliva, Stefania; Stefanoni, Paola; Marcatti, Magda; Schenone, Angelo; La Nasa, Giorgio; Crippa, Claudia; Zamagni, Elena; Riva, Marcello; Mazza, Rita; Mannina, Daniele; Sica, Simona; Bacigalupo, Andrea; Laurenti, Luca | 2024-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | Autore_2024.pdf |
| Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial | Mina R.; Musto P.; Rota-Scalabrini D.; Paris L.; Gamberi B.; Palmas A.; Aquino S.; de Fabritiis P....; Giuliani N.; De Rosa L.; Gozzetti A.; Cellini C.; Bertamini L.; Capra A.; Oddolo D.; Vincelli I.D.; Ronconi S.; Pavone V.; Pescosta N.; Cea M.; Fioritoni F.; Ballanti S.; Grasso M.; Zamagni E.; Belotti A.; Boccadoro M.; Gay F. | 2023-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Difficult‐to‐treat patients with relapsed/refractory multiple myeloma: A review of clinical trial results | Raab, Marc S.; Zamagni, Elena; Manier, Salomon; Rodriguez‐Otero, Paula; Schjesvold, Fredrik; Broi...jl, Annemiek | 2023-01-01 | EJHAEM | - | 1.01 Articolo in rivista | eJHaem - 2023 - Raab - Difficult‐to‐treat patients with relapsed refractory multiple myeloma A review of clinical trial.pdf |
| European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours | Nanni, Cristina; Kobe, Carsten; Baeßler, Bettina; Baues, Christian; Boellaard, Ronald; Borchmann,... Peter; Buck, Andreas; Buvat, Irène; Chapuy, Björn; Cheson, Bruce D; Chrzan, Robert; Cottereau, Ann-Segolene; Dührsen, Ulrich; Eikenes, Live; Hutchings, Martin; Jurczak, Wojciech; Kraeber-Bodéré, Françoise; Lopci, Egesta; Luminari, Stefano; MacLennan, Steven; Mikhaeel, N George; Nijland, Marcel; Rodríguez-Otero, Paula; Treglia, Giorgio; Withofs, Nadia; Zamagni, Elena; Zinzani, Pier Luigi; Zijlstra, Josée M; Herrmann, Ken; Kunikowska, Jolanta | 2023-01-01 | THE LANCET. HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients | Borsi E.; Mazzocchetti G.; Dico A.F.; Vigliotta I.; Martello M.; Poletti A.; Solli V.; Armuzzi S....; Taurisano B.; Kanapari A.; Pistis I.; Zamagni E.; Tacchetti P.; Pantani L.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M.; Terragna C. | 2023-01-01 | CLINICAL AND EXPERIMENTAL MEDICINE | - | 1.01 Articolo in rivista | s10238-023-01205-y.pdf; 10238_2023_1205_MOESM1_ESM.docx; 10238_2023_1205_MOESM2_ESM.docx |
| Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial | Zamagni E.; Oliva S.; Gay F.; Capra A.; Rota-Scalabrini D.; D'Agostino M.; Belotti A.; Galli M.; ...Racca M.; Zambello R.; Gamberi B.; Albano D.; Bertamini L.; Versari A.; Grasso M.; Sgherza N.; Priola C.; Fioritoni F.; Patriarca F.; De Cicco G.; Villanova T.; Pascarella A.; Zucchetta P.; Tacchetti P.; Fanti S.; Mancuso K.; Barbato S.; Boccadoro M.; Musto P.; Cavo M.; Nanni C. | 2023-01-01 | ECLINICALMEDICINE | - | 1.01 Articolo in rivista | PIIS2589537023001943.pdf; mmc1 (1).pdf |
| Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma | Mancuso K.; Zamagni E.; Solli V.; Gabrielli L.; Leone M.; Pantani L.; Rocchi S.; Rizzello I.; Tac...chetti P.; Ghibellini S.; Favero E.; Ursi M.; Talarico M.; Barbato S.; Kanapari A.; Bigi F.; Puppi M.; Terragna C.; Borsi E.; Martello M.; Poletti A.; Scata A.; Nepoti G.; Ruffini B.; Lazzarotto T.; Cavo M. | 2023-01-01 | FRONTIERS IN ONCOLOGY | - | 1.01 Articolo in rivista | 2023 Mancuso K ematologia fonc-13-1208741.pdf; Data Sheet 1.docx |
| Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma: A Case Report and Discussion of the Literature | Pignatti, Marco; Dolci, Giampiero; Zamagni, Elena; Pascale, Renato; Piccin, Ottavio; Ammar, Aless...andro; Zeneli, Flavia; Miralles, Maria Elisa Lozano; Mancuso, Katia; Cipriani, Riccardo; Viale, Pierluigi; Pacini, Davide; Martin-Suàrez, Sofia | 2023-01-01 | MICROORGANISMS | - | 1.01 Articolo in rivista | Multidisciplinary Management of Sternal Osteomyelitis Due to Klebsiella aerogenes after Open Heart Surgery in a Patient with Multiple Myeloma- A Case Report and Discussion of the Literature.pdf |
| Multiple Myeloma Prognosis From PET Images: Deep Survival Losses and Contrastive Pretraining | Morvan L.; Nanni C.; Michaud A.-V.; Jamet B.; Bailly C.; Bodet-Milin C.; Chauvie S.; Touzeau C.; ...Moreau P.; Zamagni E.; Kraeber-Bodere F.; Carlier T.; Mateus D. | 2023-01-01 | IEEE TRANSACTIONS ON RADIATION AND PLASMA MEDICAL SCIENCES | - | 1.01 Articolo in rivista | - |
| New Developments in Myeloma Treatment and Response Assessment | Kraeber-Bodere F.; Jamet B.; Bezzi D.; Zamagni E.; Moreau P.; Nanni C. | 2023-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 1.01 Articolo in rivista | 1331.full.pdf |
| Oxytocin modulates osteogenic commitment in human adipose-derived mesenchymal stem cells | Giovannamaria Petrocelli, Provvidenza Maria Abruzzo, Luca Pampanella, Riccardo Tassinari, Serena ...Marini, Martina Fazzina, Elena Zamagni, Carlo Ventura, Federica Facchin, Silvia Canaider | 2023-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Oxytocin Modulates Osteogenic Commitment in Human Adipose-Derived Stem Cells | Petrocelli, Giovannamaria; Abruzzo, Provvidenza Maria; Pampanella, Luca; Tassinari, Riccardo; Mar...ini, Serena; Zamagni, Elena; Ventura, Carlo; Facchin, Federica; Canaider, Silvia | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | Petrocelli 2023 ijms-24-10813.pdf |
| Pomalidomide combinations are a safe and effective option after daratumumab failure | Annamaria Brioli; Laura Gengenbach; Katia Mancuso; Mascha Binder; Thomas Ernst; Florian H. Heidel...; Thomas Stauch; Elena Zamagni; Inken Hilgendorf; Andreas Hochhaus; Monika Engelhardt; Marie von Lilienfeld-Toal | 2023-01-01 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | Brioli_2023.pdf; 432_2023_4637_MOESM1_ESM.pdf |